This study suggests that NBP interaction with HER3 activates a singular route for ligand-directed nanocarrier transfer across the BBB and into IC tumours, and offers advantages over using conventional BBB transporters, TfR and GLUT1, for targeting brain metastases. Here, ERBB3 is linked to neoplasm.